Twist Bioscience Corporat...
45.33
2.58 (6.04%)
At close: Jan 15, 2025, 3:59 PM
45.48
0.33%
After-hours Jan 15, 2025, 04:00 PM EST

Twist Bioscience Corporation Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
Antibody Discovery Revenue 5.30M 5.10M 4.70M 5.23M 3.39M 4.58M 7.03M 8.17M 6.53M 6.24M 6.59M 4.81M 4.10M 3.14M 3.22M 1.51M 1.20M 1.00M 1.10M 1.24M 1.31M 1.21M 1.26M 810.00K
Antibody Discovery Revenue Growth +3.86% +8.53% -10.05% +54.30% -26.05% -34.89% -13.92% +25.17% +4.58% -5.24% +36.86% +17.50% +30.45% -2.58% +113.44% +26.04% +19.32% -8.81% -11.35% -5.48% +8.24% -3.34% +55.06% n/a
Dna And Biopharma Libraries Revenue 3.62M 3.85M 3.53M 2.94M 2.66M 2.88M 2.83M 1.84M 1.50M 1.42M 1.97M 1.26M 21.45M 18.70M 16.95M 8.87M 8.64M 9.60M 9.12M 7.84M 7.86M 6.24M 6.10M 6.51M
Dna And Biopharma Libraries Revenue Growth -6.06% +8.98% +20.14% +10.53% -7.67% +1.91% +53.92% +22.48% +5.41% -27.71% +55.99% -94.12% +14.71% +10.30% +91.02% +2.76% -10.08% +5.35% +16.33% -0.33% +25.95% +2.36% -6.34% n/a
Ngs Tools Revenue 45.54M 43.40M 40.77M 39.42M 37.11M 33.24M 28.99M 24.36M 29.19M 27.79M 23.10M 19.23M 2.67M 2.02M 1.84M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Ngs Tools Revenue Growth +4.92% +6.44% +3.44% +6.23% +11.62% +14.65% +19.01% -16.54% +5.03% +20.29% +20.13% +619.72% +32.47% +9.56% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Oligo Pools Revenue 4.61M 4.17M 3.94M 4.19M 3.74M 3.73M 3.31M 3.70M 3.67M 3.26M 2.31M 3.19M 9.74M 11.16M 9.19M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Oligo Pools Revenue Growth +10.68% +5.74% -5.94% +12.01% +0.13% +12.67% -10.38% +0.82% +12.58% +41.20% -27.60% -67.26% -12.79% +21.49% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Synthetic Genes Revenue 25.65M 24.95M 22.36M 19.73M 20.05M 19.30M 18.01M 16.18M 16.42M 17.40M 14.16M 13.53M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Synthetic Genes Revenue Growth +2.81% +11.59% +13.33% -1.63% +3.89% +7.17% +11.35% -1.50% -5.63% +22.86% +4.72% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Sep 30, 2024Sep 30, 2023Sep 30, 2022Sep 30, 2021Sep 30, 2020Sep 30, 2019
Americas Revenue 193.88M 151.26M 122.47M 77.91M 1.08M 2.76M
Americas Revenue Growth +28.18% +23.51% +57.20% +7087.18% -60.74% n/a
Asia Pacific Revenue 26.52M 22.46M 19.01M 10.30M 5.12M 14.69M
Asia Pacific Revenue Growth +18.11% +18.11% +84.60% +101.37% -65.19% n/a
Emea Revenue 92.57M 71.39M 62.08M n/a 25.82M n/a
Emea Revenue Growth +29.67% +15.00% n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017
Selling, General, and Administrative Revenue 53.14M 56.79M 55.62M 52.84M 47.39M 46.06M 53.97M 42.32M 54.16M 53.69M 54.00M 51.10M 38.24M 34.48M 34.39M 28.79M 27.18M 22.49M 27.19M 26.41M 24.42M 21.32M 19.12M 15.26M 12.95M 11.26M 9.98M 9.26M 8.41M 5.92M
Selling, General, and Administrative Revenue Growth -6.43% +2.11% +5.26% +11.50% +2.90% -14.65% +27.50% -21.85% +0.87% -0.56% +5.68% +33.61% +10.92% +0.26% +19.44% +5.91% +20.89% -17.30% +2.97% +8.12% +14.55% +11.48% +25.33% +17.80% +15.08% +12.81% +7.72% +10.16% +42.07% n/a
Research and Development Revenue 21.13M 22.47M 24.15M 23.10M 23.75M 24.53M 27.38M 31.24M 29.61M 36.84M 31.23M 22.63M 19.44M 19.84M 15.79M 14.00M 11.64M 10.44M 10.63M 10.30M 10.50M 9.01M 8.91M 7.27M 6.07M 5.27M 4.71M 4.30M 4.85M 5.28M
Research and Development Revenue Growth -5.94% -6.96% +4.55% -2.72% -3.19% -10.41% -12.36% +5.53% -19.64% +17.96% +38.01% +16.39% -1.99% +25.63% +12.79% +20.32% +11.41% -1.74% +3.22% -1.90% +16.53% +1.12% +22.47% +19.92% +15.13% +11.82% +9.48% -11.30% -8.07% n/a